News & AnalysisNYBC Ventures rolls out debut $50m fundThe fund will invest in blood and cellular therapies.ByIris Dorbian15 May 2023•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingNorth AmericaUSEmerging ManagersFundraisingHealthcareBriefs